Literature DB >> 18940181

Roles of G protein and beta-arrestin in dopamine D2 receptor-mediated ERK activation.

Wenying Quan1, Ju-Heon Kim1, Paul R Albert2, HyunJin Choi1, Kyeong-Man Kim3.   

Abstract

ERK activation by dopamine D(2) receptor (D(2)R) has been extensively characterized in various cell types including brain tissues. However, the involvement of beta-arrestin in the D(2)R-mediated ERK activation is not clear yet. Three different strategies were employed in this study to determine the roles of G protein or beta-arrestin in D(2)R-mediated ERK activation. The cellular level of beta-arrestins was reduced by RNA interference and pertussis toxin-insensitive Gi proteins were used to identify the G protein involved. Finally point mutations of D(2)R in which coupling with G protein was abolished but the interaction with beta-arrestin was increased, were employed to determine whether the affinity between D(2)R and beta-arrestin is a critical factor for beta-arrestin-mediated ERK activation. Our results show that G(i2) protein is involved in D(2)R-mediated ERK activation but beta-arrestins are either not involved or play minor role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940181     DOI: 10.1016/j.bbrc.2008.10.044

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.

Authors:  Q Zhou; G Li; X Y Deng; X B He; L J Chen; C Wu; Y Shi; K P Wu; L J Mei; J X Lu; N M Zhou
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  Modulation of A₂a receptor antagonist on D₂ receptor internalization and ERK phosphorylation.

Authors:  Li Huang; Dong-Dong Wu; Lei Zhang; Lin-Yin Feng
Journal:  Acta Pharmacol Sin       Date:  2013-08-12       Impact factor: 6.150

3.  Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells.

Authors:  Jessica Deslauriers; Christian Desmarais; Philippe Sarret; Sylvain Grignon
Journal:  J Mol Neurosci       Date:  2013-11-08       Impact factor: 3.444

4.  Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.

Authors:  Tarsis F Brust; Michael P Hayes; David L Roman; Kevin D Burris; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2014-12-24       Impact factor: 4.030

Review 5.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

6.  Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.

Authors:  Guo Li; Xiaoyan Deng; Chun Wu; Qi Zhou; Linjie Chen; Ying Shi; Haishan Huang; Naiming Zhou
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

7.  GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.

Authors:  Jacob M Szereszewski; Macarena Pampillo; Maryse R Ahow; Stefan Offermanns; Moshmi Bhattacharya; Andy V Babwah
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  In silico analyses and global transcriptional profiling reveal novel putative targets for Pea3 transcription factor related to its function in neurons.

Authors:  Başak Kandemir; Ugur Dag; Burcu Bakir Gungor; İlknur Melis Durasi; Burcu Erdogan; Eray Sahin; Ugur Sezerman; Isil Aksan Kurnaz
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

9.  Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation.

Authors:  Han-Ting Chen; Nan-Yu Ruan; Jin-Chung Chen; Tzu-Yung Lin
Journal:  ASN Neuro       Date:  2012-09-24       Impact factor: 4.146

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.